The Choice of Minimally Invasive Tumor Treatment with Cryoablation 

At IceCure, we are transforming healthcare by bringing advanced, minimally invasive cryoablation treatment options to women’s health and interventional oncology.  We believe in empowering patients to take an active role in their cancer care.

It’s Your Choice. 

About Us

The Choice of Minimally Invasive Tumor Treatment with Cryoablation 

At IceCure, we are transforming healthcare by bringing advanced, minimally invasive cryoablation treatment options to women’s health and interventional oncology.  We believe in empowering patients to take an active role in their cancer care

It’s Your Choice. 

Our Mission

With nearly everyone or their loved ones being touched by cancer at some point in their lives, we are dedicated to enabling the best minimally invasive treatment choices with cryoablation, so patients can freeze their cancer, but not their lives

Choose to Believe – Our Story  

IceCure believes we must do more to improve treatment for benign and cancerous tumors. We believe in empowering both patients and their healthcare providers to expand treatment choice. We understand that patients have their own unique needs and there is no one size treatment that fits all. We believe cryoablation empowers that choice and can help turn today’s often daunting cancer treatment experience into a hopeful and restorative one. By providing outstanding results with a minimally invasive and convenient treatment experience, our ProSense Cryoablation System delivers on this promise. It’s Your Choice.

Choose IceCure

Safe

Advancing care choice 

We are bringing a true care transformation by uniquely enabling safe and convenient office-based procedures for breast tumors.  

Focused on Cryoblation

Focused on cryoablation

We are focused only on delivering quality cryoablation devices, no other ablative methods. We do not get distracted and we apply what we do best.

Proven Results

Backed by data

Our pioneering clinical research (ICE3 & ICESecret) leads the way in strengthening clinical adoption of cryoablation. It’s why physicians choose IceCure.

Choose Evidence

At IceCure, we believe in the power of strong data to support treatment choice. Our ProSense Cryoablation System has been investigated and proven effective in various clinical applications, including breast tumors, kidney cancer, lung cancer, and in palliative care.

Clinical studies with ProSense have shown strong results, with high rates of tumor destruction, and patient and physician satisfaction. In breast tumors, ICE3 interim results showed 96.91% of patients were recurrence free.

IceCure’s technology is now commercially available throughout the world with an expanding physician network who appreciate its efficacy, safety, and convenience.

Clinical Applications
**IceCure has regulatory approval worldwide. The cleared or approved clinical indications for use may vary by region. Please contact us for additional information.
Evidence
Watch Video

Choose Motivation 

Watch IceCure employees share what motivates them to work at IceCure in honor of breast cancer awareness month.  

Our Team

Eyal Shamir

Eyal Shamir

CEO
Ronen Tsimerman

Ronen Tsimerman

CFO & COO
Tlalit Bussi Tel-Tzure

Tlalit Bussi Tel-Tzure

VP Business Development & Global Marketing
Shay Levav

Shay Levav​

VP RA/QA & Clinical Applications
Naum Muchnik

Naum Muchnik

VP R&D & Engineering
Merav Nir Dotan

Merav Nir Dotan

VP Human Resources
Galit Bar Malik

Galit Bar Malik

VP Operations & Service
Shad Good

Shad Good

VP Sales North America

IceCure Medical HQ: 7 Ha’Eshel St., PO Box 3163, Caesarea, 3079504, Israel

Facebook-f Tiktok Twitter Linkedin-in Instagram Youtube
© 2023 All Rights Reserved IceCure Medical
Facebook-f Tiktok Twitter Linkedin-in Instagram Youtube
Branding by  Titan
Terms of Use    |    Privacy    |    Last Updated: April 9, 2023

EYAL SHAMIR

CEO

Prior to joining IceCure, Eyal served as CEO of medical device and export companies, including B-Cure Laser and Hanita Lenses. Eyal is a seasoned executive and has extensive experience in global business development, particularly China and Japan.

RONEN TSIMERMAN

CFO & COO

Ronen has over 15 years of experience as CFO in public and privately held companies in the medical device and communication infrastructure industries, including C. Mer Telecom Division and Insuline Medical.

TLALIT BUSSI TEL-TZURE

VP BUSINESS DEVELOPMENT & GLOBAL MARKETING

Tlalit has served in senior sales, business development and marketing positions within the healthcare industry for over 18 years, including key roles at DiA Imaging Analysis, Medical Compression Systems, Chemitec, and Trima.

SHAY LEVAV

VP RA/QA & CLINICAL APPLICATIONS

Shay brings nearly 20 years of healthcare management experience in quality assurance and regulatory affairs, previously working for Applied Spectral Imaging, Carestream and Orex (acquired by Kodak).

NAUM MUCHNIK

VP R&D & ENGINEERING

Naum has 15 years of professional experience developing a diverse range of medical device products. He previously served as R&D Mech. Manager at GE Healthcare CardioVascular & POC Ultrasound, and OP&S Manager at Medasense Biometrics.

MERAV NIR DOTAN

VP Human Resources

Merav has over 20 years of experience in human resources and organizational management. She has previously served as VP of Human Resources at Hanita Lenses, and has extensive experience in recruitment and marketing.

GALIT BAR MALIK

VP Operations & Service

Galit has over 20 years of experience in operations and supply chain management in the medical device industry after holding a variety of roles at Mazor Robotics, which was acquired by Medtronic plc.

SHAD GOOD

VP Sales North America

Mr. Shad Good, a proven and results-oriented executive, brings nearly 20 years of medical device sales and leadership experience, including a position as U.S. Senior Director of Sales at a global leader in minimally invasive breast diagnostic and therapeutic systems.